Abstract
Treatment with Imatinib is generally well-tolerated, and in the majority of patients side effects are only represented by mild to moderate haematological toxicity (Druker 2001).
However, a wide spectrum of cutaneous reaction related to imatinib administration has been reported in recent literature. In this chapter, a thorough description of cutaneous adverse events related to Imatinib treatment is provided and the pathogenetics hypothesis will be discussed.
| Lingua originale | Inglese |
|---|---|
| Titolo della pubblicazione ospite | Imatinib: chemical stucture, pharmacology, adverse effects |
| Editore | Barbara J. Larsen Nova Science Publishers, Hauppauge, NY, AV. |
| Pagine | 81-87 |
| Numero di pagine | 7 |
| Volume | 1 |
| ISBN (stampa) | 9781628083040 |
| Stato di pubblicazione | Pubblicato - 1 gen 2014 |
Keywords
- Imatinib mesylate
- melanoma